CVS Group’s (CVSG) “Buy” Rating Reiterated at Berenberg Bank
CVS Group (LON:CVSG)‘s stock had its “buy” rating restated by Berenberg Bank in a research report issued to clients and investors on Wednesday, StockTargetPrices.com reports. They currently have a GBX 1,450 ($19.52) price target on the stock. Berenberg Bank’s price target points to a potential upside of 35.17% from the stock’s previous close.
Separately, Peel Hunt reiterated a “hold” rating and issued a GBX 1,350 ($18.17) price target on shares of CVS Group in a research note on Friday, September 29th.
Shares of CVS Group (CVSG) traded up GBX 126.22 ($1.70) during mid-day trading on Wednesday, hitting GBX 1,072.72 ($14.44). 1,110,000 shares of the company were exchanged, compared to its average volume of 312,828. CVS Group has a 52-week low of GBX 13.22 ($0.18) and a 52-week high of GBX 1,500 ($20.19).
In related news, insider Richard A. Connell acquired 2,061 shares of CVS Group stock in a transaction dated Thursday, December 7th. The stock was acquired at an average price of GBX 920 ($12.38) per share, for a total transaction of £18,961.20 ($25,519.78).
About CVS Group
CVS Group plc is a holding company. The principal activities of the Company are to operate animal veterinary practices, veterinary diagnostic businesses, pet crematoria and an online pharmacy and retail business. Its segments are Veterinary Practice, Laboratories, Pet Crematoria and Animed Direct. The Veterinary Practice segment offers treatment for companion animals, equine and farm animals.
Receive News & Ratings for CVS Group plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group plc and related companies with MarketBeat.com's FREE daily email newsletter.